Basilea Pharmaceutica AG Allschwil Eulerpool ニュース

Basilea Pharmaceutica AG Allschwil Eulerpool-AFX

Basilea Pharmaceutica AG Allschwil 株式ニュース

Basilea Pharmaceutica AG Allschwilは世界中の多くのジャーナリストや投資家に注目されています。最新のBasilea Pharmaceutica AG Allschwilニュースをここにまとめています。

• ·

  Yahoo
  Basilea Pharmaceutica (BPMUF) Is a Great Choice for 'Trend' Investors, Here's Why
• ·

  Yahoo
  Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
• ·

  Yahoo
  Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
• ·

  Yahoo
  Basilea shareholders approve all proposals of the board of directors at the annual general meeting
• ·

  Yahoo
  Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics
• ·

  Yahoo
  Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications
• ·

  Thefly.com
  Basilea price target raised to CHF 94 from CHF 85 at H.C. Wainwright
• ·

  Yahoo
  Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
• ·

  Seeking Alpha
  Basilea Pharmaceutica AG GAAP EPS of CHF0.86, revenue of CHF157.6M
• ·

  Yahoo
  Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio